ACTA ENDOCRINOLOGICA (BUC)

The International Journal of Romanian Society of Endocrinology / Registered in 1938

in Web of Science Master Journal List

Acta Endocrinologica(Bucharest) is live in PubMed Central

Journal Impact Factor - click here.

Year Volume Issue First page
10.4183/aeb.
Author
Title
Abstract/Title
From through

  • Editorial

    Danila DD

    Circulating tumor cells in patients with castration resistant prostate cancer

    Acta Endo (Buc) 2008 4(1): 75-75 doi: 10.4183/aeb.2008.75

  • Endocrine Care

    Livadariu R, Timofte D, Trifan A, Danila R, Ionescu L, Sîngeap AM, Ciobanu D

    Vitamin D Deficiency, A Noninvasive Marker of Steatohepatitis in Patients with Obesity and Biopsy Proven Nonalcoholic Fatty Liver Disease

    Acta Endo (Buc) 2018 14(1): 76-84 doi: 10.4183/aeb.2018.76

    Abstract
    Context. Nonalcoholic fatty liver disease (NAFLD) includes simple steatosis, steatohepatitis (NASH) which can evolve with progressive fibrosis, cirrhosis and hepatocellular carcinoma. As liver biopsy cannot be used as a screening method, noninvasive markers are needed. Objective. The aim of this study was to test if there is a significant association between vitamin D deficit and the severity of NAFLD. Design. The patients were divided into two groups (vitamin D insufficiency/deficiency) and statistical analyses were performed on the correlation of clinical and biochemical characteristics with histopathological hepatic changes. Subjects and methods. We prospectively studied 64 obese patients referred for bariatric surgery between 2014 and 2016 to our Surgical Unit. Anthropometric, clinical measurements, general and specific biological balance were noted. NAFLD diagnosis and activity score (NAS) were evaluated on liver biopsies. Results. Increased serum fibrinogen was correlated with NASH (p=0.005) and higher NAS grade. T2DM was positively correlated with liver fibrosis (p=0.002). 84.37% of the patients had vitamin D deficit and 15.62% were vitamin D insufficient. Lobular inflammation correlated with vitamin D deficit (p=0.040). Fibrosis (p=0.050) and steatohepatitis (p=0.032) were independent predictors of low vitamin D concentration. Conclusions. Vitamin D status in conjunction with other parameters - such as T2DM - or serum biomarkers – namely fibrinogen level and PCR level - may point out the aggressive forms of NAFLD and the need for liver biopsy for appropriate management.
  • Editorial

    Danila DC

    The folliculostellate cells in pituitary gland

    Acta Endo (Buc) 2005 1(1): 89-95 doi: 10.4183/aeb.2005.89

    References
    1. Rinehart JF, Farquhar MG. Electron microscopic studies of the anterior pituitary gland. J Histochem Cytochem 1953;1:93-113.
    2. Soji T, Mabuchi Y, Kurono C, Herbert DC. Folliculo-stellate cells and intercellular communication within the rat anterior pituitary gland. Microsc Res Technol. 1997;39:138-149. [CrossRef]
    3. Allaerts W, Denef C. Regulatory activity and topological distribution of folliculo-stellate cells in rat anterior pituitary cell aggregates. Neuroendocrinology. 1989;49(4):409-18. [CrossRef]
    4. Lach B, Rippstein P, Benott BG, Staines W. Differentiating neuroblastoma of pituitary gland: neuroblastic transformation of epithelial adenoma cells. Case report. J Neurosurg. 1996;85:953-960. [CrossRef]
    5. Giometto B, Miotto D, Botteri M, et al. Folliculo-stellate cells of human pituitary adenomas: immunohistochemical study of the monocyte/macrophage phenotype expression. Neuroendocrinology. 1997;65:47-52. [CrossRef]
    6. Hentges S, Boyadjieva N, Sarkar DK. Transforming growth factor-beta3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology. 2000;141:859-67. [CrossRef]
    7. Lohrer P, Gloddek J, Hopfner U, et al. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology. 2001;74:95-105. [CrossRef]
    8. Tichomirowa M, Theodoropoulou M, Lohrer P, et al. Bacterial Endotoxin (lipopolysaccharide) Stimulates Interleukin-6 Production and Inhibits Growth of Pituitary Tumour Cells Expressing the Toll-Like Receptor 4. J Neuroendocrinol. 2005;17:152-60. [CrossRef]
    9. Ceccatelli S, Hulting AL, Zhang X, Gustafsson L, Villar M, Hokfelt T. Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci U S A. 1993;90:11292-6. [CrossRef]
    10. Johnson MD, Gray ME, Pepinsky RB, Stahlman MT. Lipocortin-1 immunoreactivity in the human pituitary gland. J Histochem Cytochem. 1990;38:1841-1845.
    11. Loxley HD, Cowell AM, Flower RJ, Buckingham JC. Modulation of the hypothalamo-pituitary adrenocortical response to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release? Neuroendoc [CrossRef]
    12. Oomizu S, Chaturvedi K, Sarkar DK. Folliculostellate cells determine the susceptibility of lactotropes to estradiol?s mitogenic action. Endocrinology. 2004;145:1473-80. [CrossRef]
    13. Hentges S, Sarkar DK. Transforming growth factor-beta regulation of estradiol-induced prolactinomas. Front Neuroendocrinol. 2001;22:340-63. [CrossRef]
    14. Kobayashi H, Fukata J, Murakami N, et al. Tumor necrosis factor receptors in the pituitary cells. Brain Res. 1997;758:45-50. [CrossRef]
    15. Herkenham M. Folliculo-stellate (FS) cells of the anterior pituitary mediate interactions between the endocrine and immune systems. Endocrinology. 2005;146:33-4.
    16. Alexander JM, Jameson JL, Bikkal HA, Schwall RH, Klibanski A. The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas. J Clin Endocrinol Metab. 1991;72:1261-7. [CrossRef]
    17. Billestrup N, Gonzalez-Manchon C, Potter E, Vale W. Inhibition of somatotroph growth and growth hormone biosynthesis by activin in vitro. Mol Endocrinol. 1990;4:356-62. [CrossRef]
    18. Alexander JM, Swearingen B, Tindall GT, Klibanski A. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids. J Clin Endocrinol Metab. 1995;80:147-52. [CrossRef]
    19. Danila DC, Inder WJ, Zhang X, et al. Activin effects on neoplastic proliferation of human pituitary tumors. J Clin Endocrinol Metab. 2000;85:1009-15. [CrossRef]
    20. Kaiser UB, Lee BL, Carroll RS, Unabia G, Chin WW, Childs GV. Follistatin gene expression in the pituitary: localization in gonadotropes and folliculostellate cells in diestrous rats. Endocrinology. 1992;130:3048-56. [CrossRef]
    21. Danila DC, Haidar JN, Zhang X, Katznelson L, Culler MD, Klibanski A. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors. J Clin Endocrinol Metab. 2001;86:2976-81. [CrossRef]
    22. Ooi GT, Tawadros N, Escalona RM. Pituitary cell lines and their endocrine applications. Mol Cell Endocrinol. 2004;228:1-21. [CrossRef]
    23. Danila DC, Zhang X, Zhou Y, et al. A human pituitary tumor-derived folliculostellate cell line. J Clin Endocrinol Metab 2000;85:1180-1187. [CrossRef]
    24. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev. 1998;19:798-827. [CrossRef]
    25. Zhang X, Zhou Y, Mehta KR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab, 2003;88:5119-26. [CrossRef]
    26. Zhang X, Sun H, Danila DC, et al. Loss of Expression of GADD45, a Growth Inhibitory Gene, in Human Pituitary Adenomas: Implications for Tumorigenesis. J. Clin. Endocrinol. Metab., 2002;873:1262-7. [CrossRef]
    27. Buckingham JC, Solito E, John C, et al. Annexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system. Cell Biochem Funct. 2003;21:217-21. [CrossRef]
    28. Solito E, Mulla A, Morris JF, Christian HC, Flower RJ, Buckingham JC. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucoc [CrossRef]
    29. Zhang X, Danila DC, Katai M, Swearingen B, Klibanski A. Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas.J Clin Endocrinol Metab. 1999;84:4652-5. [CrossRef]
  • Perspectives

    Stefanescu C, Ionescu L, R Danila, Butcovan D, Tibu R, Bilha S, Timofte D, Vulpoi C

    99mTc Mibi Thymic Scintigraphy in Diagnosis and Therapeutic Decision Making: What is Behind the Image?

    Acta Endo (Buc) 2016 12(3): 249-256 doi: 10.4183/aeb.2016.249

    Abstract
    Context. Despite CT being generally used in thymic pathology, in the case of regions with the same tissue density, only functional radioisotopic imaging can hint towards malignity. Objectives. To assess the usefulness of 99mTc MIBI scintigraphy for diagnosis and treatment planning in thymoma, in relation with the radiotracer uptake mechanism. Patients and methods. 99mTc MIBI thymic scans for 19 patients diagnosed with thymic disorders were assessed using tumor uptake ratio (UR). Specimens of thymectomies were examined and cytological assessments were correlated with the UR. Results. The UR of all surgical patients was higher than 1.2, with a 1.5 cutoff between lymphoid hyperplasia and thymoma. The UR values were correlated with the histopathologic diagnosis (Pearson correlation 0.91, significant at p<0.01). The highest UR was 3.24, found in the case of an AB thymoma where the rate lymphocytes/ epithelial cells (L/E) was 1.6. In B1 thymoma UR was 1.14 and L/E was 2.46. Conclusion. Phenotype differences between thymoma types correlate with 99mTc MIBI cellular uptake: lower rate L/E corresponds to higher UR, higher malignity potential and invasiveness. A thymic 99mTc MIBI UR higher than 1.5, corresponding to a CT tumoral image, is suggestive for a thymoma, requiring surgical treatment first.
  • Images in Endocrinology

    Ionescu L, Danila R, Vulpoi C, Ciobanu D, Lozneanu L

    Neuroendocrine Tumor of the Appendix and Tuberculosis of the Caecum in a Patient with Acute Appendicitis

    Acta Endo (Buc) 2016 12(3): 368-369 doi: 10.4183/aeb.2016.368

  • Endocrine Care

    Gatu A, Velicescu C, Grigorovici A, Danila R, Muntean V, Mogos SJ, Mogos V, Vulpoi C, Preda C, Branisteanu D

    The Volume of Solitary Parathyroid Adenoma is Related to Preoperative PTH and 250H-D3, but Not to Calcium Levels

    Acta Endo (Buc) 2017 13(4): 441-446 doi: 10.4183/aeb.2017.441

    Abstract
    Purpose. To correlate the volume of parathyroid adenomas with the hormonal and metabolic profile at patients diagnosed with primary hyperparathyroidism (pHPTH). Patients and Methods. Cross-sectional multicentric study, enrolling 52 patients with pHPTH from two medical institutions. Serum calcium and PTH were evaluated in all patients before surgery, whereas 25OHD3 was measured only in the 33 patients recruited form one medical unit. The volume of parathyroid adenoma was measured by using the formula of a rotating ellipsoid. Results. We observed a significant correlation of the volume of parathyroid adenomas with PTH at patients from the two units and in the whole group (p < 0.0001), but not with serum calcium (p = 0.494). Twenty-five out of the 33 patients at whom 25OHD3 was measured had levels in the range of deficiency. 25OHD3 was not correlated with PTH or calcium levels, but was negatively correlated to the adenoma volume and positively to the PTH/volume ratio (p = 0.041 and p = 0.048, respectively). Conclusions. The volume of parathyroid adenoma seems to be related to preoperative PTH and 25OHD3, but not to calcium level. Vitamin D deficiency is frequently found at patients with pHPTH and may contribute to particular disease profiles, including larger parathyroid adenomas.
  • Endocrine Care

    Velicescu C, Branisteanu D, Grigorovici A, Gatu A, Preda C, Mogos V, Danila R

    Quick Intraoperative PTH Assay Improves Cure Rate of Minimally Invasive Surgery in Patients with Primary Hyperparathyroidism

    Acta Endo (Buc) 2015 11(4): 457-462 doi: 10.4183/aeb.2015.457

    Abstract
    Purpose. We checked the advantage of intraoperative quick PTH (iqPTH) for improving cure rate of patients operated for primary hyperparathyroidism (PHPTH) by using minimally invasive surgery. Methods. We compared two groups of patients diagnosed with PHPTH by preoperatory localized single parathyroid adenoma (PA) submitted to minimal invasive surgery with histological confirmation. Patients from a control group (C) were operated without measuring intraoperative PTH, whereas in the second group iqPTH was assessed after adenoma excision and before wound suture. When quick PTH dropped less than 50%, conversion to open surgery and bilateral exploration followed. Results. Six of the 40 patients from the C group (15%) had persistently elevated postoperative PTH, needing reintervention. High intraoperative PTH levels persisted in two of the 13 patients from the iqPTH group (15.4%), but conversion to open surgery allowed localizing and excision of preoperatory undetected supplementary PA, increasing success rate to 100% (p < 0.05). Conclusions. Assessment of iqPTH in PHPTH before wound suture provides reliable confirmation of accurate adenoma removal. Persistence of high PTH levels after adenoma removal suggests multiple gland disease and requires conversion to bilateral neck exploration in order to increase cure rate.
  • Images in Endocrinology

    Danila R, Livadariu R, Stefanescu C, Ciobanu D, Ionescu L

    Radioguided Mediastinal Parathyroidectomy in a Patient with Persistent Renal Hyperparathyroidism

    Acta Endo (Buc) 2017 13(4): 514-514 doi: 10.4183/aeb.2017.514

  • Images in Endocrinology

    Danila R, Ionescu L, Livadariu R, Vulpoi C, Ciobanu D, Ungureanu MC

    Primary Hydatid Cyst of the Thyroid

    Acta Endo (Buc) 2015 11(4): 529-529 doi: 10.4183/aeb.2015.529

  • Actualities in medicine

    Danila R, Livadariu R, Branisteanu D

    Calcitonin Revisited in 2020

    Acta Endo (Buc) 2019 15(4): 544-548 doi: 10.4183/aeb.2019.544

    Abstract
    Calcitonin (CT) is a polypeptidic hormone specifically secreted by the thyroid parafollicular cells (C cells) and tangentially involved in human phosphocalcic and bone metabolism. CT from other species (e.g. salmon) is more potent than human CT and has limited therapeutic applications. The neoplastic proliferation of C cells leads to medullary thyroid carcinoma (MTC) generally characterized by an increase of CT secretion. Serum CT is therefore the ideal marker for MTC and can confirm its presence at an early stage, as well as the follow up of its remission or progression/relapse/survival after surgery. There are, however, controversies such as the necessity of CT screening in patients with thyroid nodules, or particular situations causing false positive or false negative results. Our minireview also deals with an up-to-date of surgical procedures for MTC, as well as with non-surgical therapy.